We are live on ! Find out more
SVA

Sinovac Biotech

Delisted

SVA was delisted on the 22nd of February, 2019.

37 hedge funds and large institutions have $66.5M invested in Sinovac Biotech in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital inflows, than outflows

Capital inflows: $4.52M | Capital outflows: $4.18M

0.11% more ownership

Funds ownership: 26.21% → 26.32% (+0.11%)

8% less funds holding

Funds holding: 40 → 37 (-3)

23% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 13

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

Holders
37
Holders Change
-3
Holders Change %
-7.5%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
13
Closed
7
Calls
$11​K
Puts
–
Net Calls
+$11​K
Net Calls Change
+$89​K

SVA Hedge Fund Activity: Q2 2015 in Review

37 of the 3,729 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech (SVA) for Q2 2015, worth a combined $66.5M — up 6.3% from $62.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of SVA and 5 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 10 added.

The largest buyer was First Manhattan, opening a new position worth an estimated $3.19M. The largest seller was Wellington Management Group, cutting an estimated $2.65M.

  • 37 institutional investors held Sinovac Biotech (SVA) as of Q2 2015, down from 40 in Q1 2015.
  • Funds reported $66.5M of Sinovac Biotech stock for Q2 2015, up 6.3% quarter-over-quarter.
  • 5 funds opened new Sinovac Biotech positions in Q2 2015 and 7 closed out, a net change of -2 holders.
  • The largest Sinovac Biotech buyer in Q2 2015 was First Manhattan, an estimated $3.19M added.
  • The largest Sinovac Biotech seller in Q2 2015 was Wellington Management Group, an estimated $2.65M sold.

Based on aggregated 13F filings for Q2 2015.